<!DOCTYPE html>
<html>
<head>
	<meta charset="utf-8">
	<title>Novartis Home Page</title>
	<link href="https://fonts.googleapis.com/css?family=Oswald" rel="stylesheet">
	<link href="https://fonts.googleapis.com/css?family=Roboto+Condensed" rel="stylesheet">
	<link rel="stylesheet" href=style.css>
</head>

<body>
<header>
	<h1> <img src="image/novartis-logo.svg" alt="Novartis"></h1>

	<ul>
		<li>Join Us</li>
	</ul>
</header>

	<h2>At Novartis, we are reimagining medicine</h2>
	
	<h3>Navigate Novartis</h3>

	<ul>
		<li><a href="https://www.novartis.com/our-focus/patients-caregivers">Patients & Caregivers</a></li>
		<li><a href="https://www.novartis.com/our-focus/healthcare-professionals">Healthcare Professionals</a></li>
		<li><a href="https://www.novartis.com/news">Media</a></li>
		<li><a href="https://www.novartis.com/investors">Investors</a></li>
	</ul>

	<h2>Novartis R&D Update</h2>
	<img src="https://www.novartis.com/sites/www.novartis.com/files/styles/landing_page_1600x800/public/world-heart-day-2018-stripe-randd-image.jpg?itok=u45FnF9B" alt="observing series or testubes under microscope" >

	<p>Novartis highlights industry-leading development pipeline.</p>

	<footer><a href="https://www.novartis.com/news/media-releases/novartis-rd-update-highlights-industry-leading-development-pipeline-including-potential-blockbusters-and-advanced-therapy-platforms">Read more</a>
	</footer>

	<section>
	<div>
		<blockquote>
		<q>We progressed our breakthrough medicines pipeline including our leading advanced therapy platforms in cell and gene and continued our strong operational performance.</q>
		<cite><b>Vas Narasimhan</b>, Novartis CEO</cite>	
	</blockquote>
	</div>
	<div>
	<img class="ceo" src="https://www.novartis.com/sites/www.novartis.com/files/styles/landing_page_1600x800/public/vas-quote-homepage-image.jpg?itok=Ca_U-fkp">
	</div>
</section>

<section>
	<div>
		<a href="https://www.novartis.com/news/media-releases/novartis-appoints-dr-klaus-moosmayer-chief-ethics-risk-and-compliance-officer">Novartis appoints Dr. Klaus Moosmayer as Chief Ethics Risk and Compliance Officer</a>
	</div>
	<div>
		<a href="https://www.novartis.com/news/media-releases/novartis-receives-european-commission-approval-its-car-t-cell-therapy-kymriah-tisagenlecleucel">Novartis receives European Commission approval of its CAR-T cell therapy, Kymriah® (tisagenlecleucel)</a>
	</div>
	<div>
		<a href="https://www.novartis.com/news/media-releases/novartis-divest-sandoz-us-dermatology-business-and-generic-us-oral-solids-portfolio-aurobindo">Novartis to divest the Sandoz US dermatology business and generic US oral solids portfolio to Aurobindo</a>
	</div>
	<div>
		<a href="https://www.novartis.com/news/media-releases/novartis-announces-fda-and-ema-filing-acceptance-siponimod-first-and-only-drug-shown-meaningfully-delay-disability-progression-typical-spms-patients">Novartis announces FDA and EMA filing acceptance of siponimod, the first and only drug shown to meaningfully delay disability progression in typical SPMS patients</a>
	</div>
	
</section>

<footer>Media releases</footer>

<div>
	<footer>
	<h2>Novartis Global</h2>

	<ul>
		<li>
			<h3>Navigate Novartis</h3>
			<ul>
				<li><a href="https://www.novartis.com/our-focus/patients-caregivers"> Patients & Caregivers</a></li>
				<li><a href="https://www.novartis.com/our-focus/healthcare-professionals">Healthcare Professionals</li>
				<li><a href="https://www.novartis.com/investors">Investors</a></li>
				<li><a href="https://www.novartis.com/news">Media</a></li>
			</ul>
		</li>

		<li>
			<h3>Contact Us</h3>
			<ul>
				<li><a href="https://www.novartis.com/our-company/contact-us">Global Contacts</a></li>
				<li><a href="https://www.novartis.com/our-company/contact-us/office-locations">Office Locations</a></li>
				<li><a href="https://www.novartis.com/our-company/contact-us/investor-contacts">Investors</li>
				<li><a href="https://www.novartis.com/our-company/contact-us/media-contacts"></a>Media</li>
			</ul>
		</li>
		<li>
			<h3>About Novartis</h3>
			<ul>
				<li><a href="https://www.novartis.com/our-company"></a>Our Company</li>
				<li><a href="https://www.novartis.com/our-focus"></a>Our Focus</li>
				<li><a href="https://www.novartis.com/our-science">Our Science</a></li>
				<li><a href="https://www.novartis.com/stories"></a>Our Stories</li>
			</ul>
		</li>
		<li>
			<h3>Our Portfolio</h3>
			<ul>
				<li><a href="https://www.novartis.com/our-company/global-product-portfolio">Global Product Portfolio
				</a></li>
				<li><a href="https://www.novartis.com/our-science/novartis-global-pipeline">Global Clinical Pipeline</a></li>
			</ul>
		</li>
		<li>
			<h3>Join Us</h3>
			<ul>
				<li><a href="https://www.novartis.com/careers/career-search">Career Search</a></li>
			</ul>
		<div>
			<h2>Subscribe to Novartis</h2>
			<ul>
				<li><img src=""><a href="https://twitter.com/novartis">Twitter</a></li>
				<li><a href="https://www.linkedin.com/company/novartis">LinkedIn</a></li>
				<li><a href="https://www.youtube.com/user/Novartis">Youtube</a></li>
				<li><a href="https://www.facebook.com/novartis">Facebook</a></li>
				<li><a href="https://www.pinterest.com/novartis/">Pintrest</a></li>
				<li><a href="https://www.instagram.com/novartis/">instagram</a></li>
			</ul>
		</div>
		<div>
			<h2>Novartis Site Directory</h2>
		</div>
	</footer>
	</div>
	<div>
		<h3>© 2018 Novartis AG</h3>
		<ul>
			<li><a href="https://www.novartis.com/terms-use">Terms of Use</a></li>
			<li><a href="https://www.novartis.com/privacy-policy">Privacy Policy</a></li>
			<li><a href="https://www.novartis.com/our-company/contact-us">Contact Us</a></li>
			<li><a href="https://www.novartis.com/sitemap.xml">Site Map</a></li>

		</ul>
		<h3>This site is intended for a global audience.</h3>
	</div>
</body>
</html>